Data as of Sep 14, 2026 · Based on 3,293,187 AI responses across 10,525 prompts · See how Parse measures this
Novo Nordisknovonordisk.com · Low evidenceNovo Nordisk is a healthcare company that develops treatments for chronic diseases, including obesity and liver disease. Its products include Wegovy® (semaglutide) for weight loss and an oral GLP-1 medication for obesity.
Parse Score